Shiraz E-Medical Journal

Published by: Kowsar

Anti-Proliferative Effects of Human Anti-FZD7 Single Chain Antibodies on Colorectal Cancer Cells

Mehdi Fazeli 1 , Neda Zarei 1 , Bahareh Moazen 2 , 3 and Foroogh Nejatollahi 2 , 3 , *
Authors Information
1 Department of Biotechnology, School of Veterinary Medicine, Shiraz University, Shiraz, IR Iran
2 Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Recombinant Antibody Laboratory, Department of Immunology, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Shiraz E-Medical Journal: March 2017, 18 (3); e59936
  • Published Online: February 26, 2017
  • Article Type: Research Article
  • Received: January 5, 2017
  • Revised: February 14, 2017
  • Accepted: February 20, 2017
  • DOI: 10.5812/semj.45219

To Cite: Fazeli M, Zarei N, Moazen B, Nejatollahi F. Anti-Proliferative Effects of Human Anti-FZD7 Single Chain Antibodies on Colorectal Cancer Cells, Shiraz E-Med J. 2017 ; 18(3):e59936. doi: 10.5812/semj.45219.

Abstract
Copyright © 2017, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Hisamuddin IM, Yang VW. Molecular Genetics of Colorectal Cancer: An Overview. Curr Colorectal Cancer Rep. 2006; 2(2): 53-9[PubMed]
  • 2. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene. 2006; 25(57): 7531-7[DOI][PubMed]
  • 3. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007; 56(3): 417-25[DOI][PubMed]
  • 4. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004; 6(5): 497-506[DOI][PubMed]
  • 5. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004; 36(4): 417-22[DOI][PubMed]
  • 6. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia. 2004; 6(1): 7-14[PubMed]
  • 7. King TD, Zhang W, Suto MJ, Li Y. Frizzled7 as an emerging target for cancer therapy. Cell Signal. 2012; 24(4): 846-51[DOI][PubMed]
  • 8. Polakis P. Wnt signaling and cancer. Genes Dev. 2000; 14(15): 1837-51[PubMed]
  • 9. Ueno K, Hiura M, Suehiro Y, Hazama S, Hirata H, Oka M, et al. Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia. 2008; 10(7): 697-705[PubMed]
  • 10. Sagara N, Toda G, Hirai M, Terada M, Katoh M. Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7. Biochem Biophys Res Commun. 1998; 252(1): 117-22[DOI][PubMed]
  • 11. Vincan E, Darcy PK, Smyth MJ, Thompson EW, Thomas RJ, Phillips WA, et al. Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation. 2005; 73(4): 142-53[DOI][PubMed]
  • 12. Vincan E, Darcy PK, Farrelly CA, Faux MC, Brabletz T, Ramsay RG. Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene. 2007; 26(16): 2340-52[DOI][PubMed]
  • 13. Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M. scFv antibody: principles and clinical application. Clin Dev Immunol. 2012; 2012: 980250[DOI][PubMed]
  • 14. Monnier P, Vigouroux R, Tassew N. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies. 2013; 2(2): 193-208[DOI]
  • 15. Nejatollahi F, Malek-Hosseini Z, Mehrabani D. Development of single chain antibodies to P185 tumor antigen. Iran Red Crescent Med J. 2008; 2008(4): 298-302
  • 16. Mohammadi M, Nejatollahi F. 3D structural modeling of neutralizing scFv against glycoprotein-D of HSV-1 and evaluation of antigen-antibody interactions by bioinformatic methods. Int J Pharm Bio Sci. 2014; 5(4): 835-47
  • 17. Moazen B, Ebrahimi E, Nejatollahi F. Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections. Jundishapur J Microbiol. 2016; 9(3)[DOI][PubMed]
  • 18. Mohammadi M, Nejatollahi F, Sakhteman A, Zarei N. Insilico analysis of three different tag polypeptides with dual roles in scFv antibodies. J Theor Biol. 2016; 402: 100-6[DOI][PubMed]
  • 19. Cheng Y, Li Z, Xi H, Gu T, Yuan R, Chen X, et al. A VL-linker-VH Orientation Dependent Single Chain Variable Antibody Fragment Against Rabies Virus G Protein with Enhanced Neutralizing Potency in vivo. Protein Pept Lett. 2016; 23(1): 24-32[PubMed]
  • 20. Nejatollahi F, Silakhori S, Moazen B. Isolation and Evaluation of Specific Human Recombinant Antibodies from a Phage Display Library against HER3 Cancer Signaling Antigen. Middle East J Cancer. 2014; 5(3): 137-44
  • 21. Mohammadi M, Nejatollahi F, Ghasemi Y, Faraji SN. Anti-Metastatic and Anti-Invasion Effects of a Specific Anti-MUC18 scFv Antibody on Breast Cancer Cells. Appl Biochem Biotechnol. 2017; 181(1): 379-90[DOI][PubMed]
  • 22. Li K, Zettlitz KA, Lipianskaya J, Zhou Y, Marks JD, Mallick P, et al. A fully human scFv phage display library for rapid antibody fragment reformatting. Protein Eng Des Sel. 2015; 28(10): 307-16[DOI][PubMed]
  • 23. Nejatollahi F, Jaberipour M, Asgharpour M. Triple blockade of HER2 by a cocktail of anti-HER2 scFv antibodies induces high antiproliferative effects in breast cancer cells. Tumour Biol. 2014; 35(8): 7887-95[DOI][PubMed]
  • 24. Cianfriglia M, Fiori V, Dominici S, Zamboni S, Flego M, Luisa Dupuis M, et al. CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors. Open Pharm J. 2011; 6(1)
  • 25. Bengochea A, de Souza MM, Lefrancois L, Le Roux E, Galy O, Chemin I, et al. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer. 2008; 99(1): 143-50[DOI][PubMed]
  • 26. Yang L, Kim CCH, Yen Y. FZD7 in triple negative breast cancer cells. 2011;
  • 27. Tanaka S, Akiyoshi T, Mori M, Wands JR, Sugimachi K. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A. 1998; 95(17): 10164-9[PubMed]
  • 28. Kirikoshi H, Sekihara H, Katoh M. Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. Int J Oncol. 2001; 19(1): 111-5[PubMed]
  • 29. Khan NI, Bradstock KF, Bendall LJ. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol. 2007; 138(3): 338-48[DOI][PubMed]
  • 30. Pode-Shakked N, Harari-Steinberg O, Haberman-Ziv Y, Rom-Gross E, Bahar S, Omer D, et al. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target. Oncogene. 2011; 30(14): 1664-80[DOI][PubMed]
  • 31. Tiwary S, Xu L. FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells. PLoS One. 2016; 11(1)[DOI][PubMed]
  • 32. Dai H, Wang Y, Lu X, Han W. Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy. J Natl Cancer Inst. 2016; 108(7)[DOI][PubMed]
  • 33. Younesi V, Nejatollahi F. Induction of anti-proliferative and apoptotic effects by anti-IL-25 receptor single chain antibodies in breast cancer cells. Int Immunopharmacol. 2014; 23(2): 624-32[DOI][PubMed]
  • 34. Nelson PN, Reynolds GM, Waldron EE, Ward E, Giannopoulos K, Murray PG. Monoclonal antibodies. Mol Pathol. 2000; 53(3): 111-7[PubMed]
  • 35. Ehsaei B, Nejatollahi F, Mohammadi M. Specific Single Chain Antibodies Against A Neuronal Growth Inhibitor Receptor, Nogo Receptor 1: Promising New Antibodies for the Immunotherapy of Multiple Sclerosis. Shiraz E-Med J. 2017; 18(1)
  • 36. Nejatollahi F, Abdi S, Asgharpour M. Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells. J Oncol. 2013; 2013: 839831[DOI][PubMed]
  • 37. Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan YC, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene. 2011; 30(43): 4437-46[DOI][PubMed]
  • 38. Van Hoof D, Dormeyer W, Braam SR, Passier R, Monshouwer-Kloots J, Ward-van Oostwaard D, et al. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res. 2010; 9(3): 1610-8[DOI][PubMed]
  • 39. Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, et al. Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009; 101(8): 1374-81[DOI][PubMed]
  • 40. Ranjbar R, Nejatollahi F, Nedaei Ahmadi AS, Hafezi H, Safaie A. Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 41. Nejatollahi F, Ranjbar R, Younesi V, Asgharpour M. Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs. Oncol Res. 2013; 20(8): 333-40[DOI][PubMed]
  • 42. Carrasco-Garcia E, Saceda M, Martinez-Lacaci I. Role of receptor tyrosine kinases and their ligands in glioblastoma. Cells. 2014; 3(2): 199-235[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments